Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sherif S. Farag, MD, PhD
Ohio State University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- University of Illinois Cancer Center
Chicago, Illinois, United States
- Greenebaum Cancer Center at University of Maryland Medical Center
Baltimore, Maryland, United States
- Union Hospital Cancer Program at Union Hospital
Elkton, Maryland, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Cancer Institute of New Jersey at Cooper - Voorhees
Voorhees Township, New Jersey, United States
- New York Weill Cornell Cancer Center at Cornell University
New York, New York, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Columbus, Ohio, United States
- Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Fox Chase Cancer Center - Philadelphia
Philadelphia, Pennsylvania, United States
- Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
Pittsburgh, Pennsylvania, United States
- Virginia Commonwealth University Massey Cancer Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2003
- Primary completion
- 31 Aug 2008
- Completion
- 1 Nov 2014
- Last update posted
- 3 Nov 2021
- Registered enrollment
- 39
- Registry id
- NCT00074035
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.